For most companies, the honest answer is: nobody knows.
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
On March 31, 2026, the popular HTTP client Axios experienced a supply chain attack, causing two newly published npm packages ...
Anthropic is scrambling to contain the leak, but the AI coding agent is spreading far and wide and being picked apart.
Microsoft released TypeScript 6.0 on March 23, the last version built on the original JavaScript codebase, with three post-RC changes and a wave of deprecations designed to ready codebases for the ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results